How is the DBV Technologies - ADR today?

The DBV Technologies - ADR today is trading in the green, up by 4.95% at 9.55.

How has DBV Technologies - ADR performed historically?

The DBV Technologies - ADR is currently trading up 4.95% on an intraday basis in the past week the index rose 4.60%. The index has been up 96.10% in the past quarter and rose 91.38% in the past year. You can view this in the overview section.

What is DBV Technologies - ADR Annual Net Profit?

DBV Technologies - ADR Annual Net Profit fell 56.64% in the last year to $113.92 M. Its sector's average net profit growth for the last fiscal year was -14.01%.

What is DBV Technologies - ADR Price to Earning Ratio?

DBV Technologies - ADR Price to Earning Ratio is -2.3, which is negative.

What is DBV Technologies - ADR Stock Price?

DBV Technologies - ADR Stock Price rose 91.38% and outperformed its sector by 80.46% in the past year.

What is DBV Technologies - ADR Quarterly Net profit?

DBV Technologies - ADR Quarterly Net profit rose 0.97% YoY to $27.08 M. Its sector's average net profit growth YoY for the quarter was -236.8%.

What is DBV Technologies - ADR Debt to Equity Ratio?

DBV Technologies - ADR Debt to Equity Ratio of 0.28 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is DBV Technologies - ADR Return on Equity(ROE)?

DBV Technologies - ADR Return on Equity(ROE) for the last financial year was -135.96%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is DBV Technologies - ADR Mutual Fund Holding?

DBV Technologies - ADR Mutual Fund Holding decreased by 0% in the last quarter to 0.19.

What is DBV Technologies - ADR Institutional Holding?

DBV Technologies - ADR Institutional Holding decreased by 1.37% in the last quarter to 13.72.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
DBV TECHNOLOGIES - ADR

DBV Technologies - ADR XNAS: DBVT

DBV Technologies - ADR Live Share Price Today, Share Analysis and Chart

Name: DBV Technologies - ADR: Is Infosys Ltd. worth buying?
Item: DBV Technologies - ADR
Rating: 1.85625
Author: Trendlyne DVM scores

about

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...

9.55 0.45 (4.95%)

25.27% Fall from 52W High

17,121

XNAS Volume

XNAS 16 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.5 / 100

Technically Bullish

73.8 / 100

No estimates available

DBV Technologies - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

DBV Technologies - ADR Live Share Price Today, Share Analysis and Chart

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...

25.27% Fall from 52W High

SWOT Analysis

DBV Technologies - ADR Live Price Chart

DBV Technologies - ADR FAQ

How is DBV Technologies - ADR today?

DBV Technologies - ADR today is trading in the green, and is up by 4.95% at 9.55.

How has DBV Technologies - ADR performed historically?

DBV Technologies - ADR is currently trading up 4.95% on an intraday basis. In the past week the stock rose 4.60%. stock has been up 96.10% in the past quarter and rose 91.38% in the past year. You can view this in the overview section.